TITLE

The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma

AUTHOR(S)
Hellerbrand, C.; Amann, T.; Schlegel, J.; Wild, P.; Bataille, F.; Spruss, T.; Hartmann, A.; Bosserhoff, A-K.
PUB. DATE
February 2008
SOURCE
Gut;Feb2008, Vol. 57 Issue 2, p243
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Melanoma inhibitory activity 2 (MIA2) is a novel gene of the MIA gene family. The selective expression of MIA2 in hepatocytes is controlled by hepatocyte nuclear factor (HNF) 1 binding sites in the MIA2 promotor. In contrast, in most hepatocellular carcinomas (HCC) MIA2 expression is down-regulated or lost. Aim: In this study we examined the regulation and functional role of MIA2 in hepatocancerogenesis. Methods and results: In HCC cell lines and tissues HNF-1 expression was lower than in primary human hepatocytes (PHH) and corresponding non-tumorous tissue, respectively, and correlated significantly with the down-regulation of MIA2 expression. Re-expression of HNF-1 in HCC cells reinduced MIA2 in HCC cells to similar levels as found in PHH. Further, MIA2 was re-expressed in HCC cell lines by stable transfection, and the generated cell clones revealed a strongly reduced invasive potential and proliferation rate in vitro. In line with these findings treatment of F-ICC cells with recombinant MIA2 inhibited proliferation and invasion. In nude mice MIA2 re-expressing F-ICC cells grew significantly slower and revealed a less invasive growth pattern. Immunohistochemical analysis of a tissue microarray containing HCC and corresponding non-cancerous liver tissue of 85 patients confirmed reduced MIA2 expression in HCC. Furthermore, MIA2 negative HCC tissue showed a significantly higher Ki67 labelling index and loss of MIA2 expression correlated significantly with more advanced tumour stages. Conclusion: This study presents MIA2 as an inhibitor of HCC growth and invasion both in vitro and in vivo, and consequently, as a tumour suppressor of HCC. Further, our findings indicate a novel mechanism, how loss of HNF-1 expression in HCC affects tumorigenicity via down-regulation of MIA2.
ACCESSION #
28843120

 

Related Articles

  • An N-terminal Region of mot-2 Binds to p53 In Vitro. Kaul, Sunil C; Reddel, Roger R; Mitsui, Youji; Wadhwa, Renu // Neoplasia;Mar2001, Vol. 3 Issue 2, p110 

    The mouse mot-2 protein was earlier shown to bind to the tumor suppressor protein, p53. The mot-2 binding site of p53 was mapped to C-terminal amino acid residues 312–352, which includes the cytoplasmic sequestration domain. In the present study, we have found that both mot-1 and mot-2...

  • The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis. Habbous, Steven; Przech, Sebastian; Acedillo, Rey; Sarma, Sisira; Garg, Amit X.; Martin, Janet // Nephrology Dialysis Transplantation;Jan2017, Vol. 32 Issue 1, p111 

    Background. It remains unclear which phosphate binders should be preferred for hyperphosphatemia management in chronic kidney disease (CKD). Methods. We performed a systematic review and meta-analysis of randomized trials comparing sevelamer or lanthanum with other phosphate binders in CKD....

  • Several conserved positively charged amino acids in OATP1B1 are involved in binding or translocation of different substrates. Weaver, Yi M.; Hagenbuch, Bruno // Journal of Membrane Biology;Aug2010, Vol. 236 Issue 3, p279 

    OATP1B1 and 1B3 are related transporters mediating uptake of numerous compounds into hepatocytes. A putative model of OATP1B3 with a "positive binding pocket" containing conserved positively charged amino acids was predicted (Meier-Abt et al. J Membr Biol 208:213-227, 2005). Based on this model,...

  • New mechanism of tolerance induction in cancer. Leavy, Olive // Nature Reviews Immunology;Aug2007, Vol. 7 Issue 8, p580 

    The article presents a study which examines the mechanism of myeloid-derived suppressor cells (MDSCs) in inducing CD8+ T-cell tolerance by blocking peptide-MHC-TCR (T-cell receptor) binding through the nitration of TCR-CD8 complex. The study utilizes an experimental mouse model to assess the...

  • The contribution of the RING finger domain of MDM2 to cell cycle progression. Argentini, Manuela; Barboule, Nadia; Wasylyk, Bohdan // Oncogene;8/10/2000, Vol. 19 Issue 34, p3849 

    The MDM2 oncoprotein binds to p53 and abrogates p53-mediated G1 arrest and apoptosis. We show that MDM2 over-expression accelerates cell cycle progression of RPMI2650 cells by overcoming the negative effect of endogenous wild type p53 at the G1/S checkpoint. The interaction with p53 and...

  • Identification of RB18A, a 205 kDa new p53 regulatory protein which shares antigenic and functional properties with p53. Drané, Pascal; Barel, Monique; Balbo, Michelle; Frade, Raymond // Oncogene;12/18/97, Vol. 15 Issue 25, p3013 

    Immunological screening with the anti-p53 moAb, PAb1801 of a cDNA expression library, prepared from human B lymphoma cells, led us to identify a new human 205 kDa protein called RB18A for ‘Recognized By PAb1801 moAntibody’ Immunoblotting or immunoprecipitation of fusion protein or...

  • Analysis of the Nse3/MAGE-Binding Domain of the Nse4/EID Family Proteins. Guerineau, Marc; Kriz, Zdenek; Kozakova, Lucie; Bednarova, Katerina; Janos, Pavel; Palecek, Jan // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: The Nse1, Nse3 and Nse4 proteins form a tight sub-complex of the large SMC5-6 protein complex. hNSE3/ MAGEG1, the mammalian ortholog of Nse3, is the founding member of the MAGE (melanoma-associated antigen) protein family and the Nse4 kleisin subunit is related to the EID (E1A-like...

  • The Majority of Autologous Cytolytic T-Lymphocyte Clones Derived from Peripheral Blood Lymphocytes of a Melanoma Patient Recognize an Antigenic Peptide Derived from Gene Pmel17/gp100. Zarour, Hassane; De Smet, Charles; Lehmann, Frédéric; Marchand, Marie; Lethé, Bernard; Romero, Pedro; Boon, Thierry; Renauld, Jean-Christophe // Journal of Investigative Dermatology;Jul96, Vol. 107 Issue 1, p63 

    Anti-melanoma cytolytic T-lymphocyte (CTL) clones were derived from peripheral blood lymphocytes of HLA-A2 melanoma patient LB265 after stimulation with the autologous tumor cell line LB265-MEL, which showed high expression of melanocyte-lineage specific genes. Of 55 CTL clones, 46 recognized...

  • Analysis of the Nse3/MAGE-Binding Domain of the Nse4/EID Family Proteins. Guerineau, Marc; Kriz, Zdenek; Kozakova, Lucie; Bednarova, Katerina; Janos, Pavel; Palecek, Jan // PLoS ONE;Apr2012, Vol. 7 Issue 4, p1 

    Background: The Nse1, Nse3 and Nse4 proteins form a tight sub-complex of the large SMC5-6 protein complex. hNSE3/ MAGEG1, the mammalian ortholog of Nse3, is the founding member of the MAGE (melanoma-associated antigen) protein family and the Nse4 kleisin subunit is related to the EID (E1A-like...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics